ArticleNature communications2025
Sterol-C4-methyl-oxidase Erg251 governs Candida albicans hypoxic growth, commensalism and virulence.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Intestinal-colonizing Candida albicans is a primary source of systemic infection where it translocates across intestinal barriers into the bloodstream leading to disseminated candidiasis. To persist in the gastrointestinal tract, C. albicans must adapt to complex environments, including extreme hypoxic conditions (EHC). Here, we performed a functional genomic screen to identify genes important for C. albicans fitness under EHC. We discovered that one of the two C. albicans sterol C4-methyl oxidases, Erg251, is specifically required for producing ergosterol, an essential component for fungal membrane, in low oxygen conditions. Deleting Erg251 or mutating key amino acid residues for its function under EHC impaired C. albicans virulence and colonization in mouse models of systemic infection and commensalism, respectively. Selective inhibitors of fungal sterol C4-methyl oxidases, inhibit C. albicans growth in vitro and in a nematode infection model, showing therapeutic potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.